GoodRx Reports Third Quarter 2024 Results [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
leading prescription savings platform in the U.S., has released its financial results for the third quarter of 2024. Third Quarter 2024 Highlights Revenue and Adjusted Revenue of $195.3 million Net income of $4.0 million; Net income margin of 2.0% Adjusted Net Income of $31.9 million; Adjusted Net Income Margin of 16.4% Adjusted EBITDA of $65.0 million; Adjusted EBITDA Margin of 33.3% Net cash provided by operating activities of $86.9 million Exited the quarter with over 7 million consumers of prescription-related offerings "In a world where there is increasing attention on medicine affordability and access, we believe the strategic high ground belongs to brands and companies that benefit patients and remove friction from a complicated healthcare ecosystem. At GoodRx, that's our North Star and we believe it's enabled us to gain share in our category and strengthen our value proposition throughout 2024," said Scott Wagner, Interim Chief Executive Officer of GoodRx. "We
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Prof G's mother being ‘underinsured' fueled him to get rich — says America ‘focuses on shareholders' over wellbeing [Yahoo! Finance]Yahoo! Finance
- GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Seven Reasons Regular Health Checkups With Your Doctor Save You Money [Forbes]Forbes
- GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Morgan Stanley from $7.00 to $6.00. They now have an "equal weight" rating on the stock.MarketBeat
- GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesBusiness Wire
GDRX
Earnings
- 11/7/24 - Beat
GDRX
Sec Filings
- 12/23/24 - Form 4
- 12/18/24 - Form SCHEDULE
- 12/18/24 - Form SCHEDULE
- GDRX's page on the SEC website